Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (18)

« Back to Publications

Preexisting Neutralizing Antibodies against Different Adeno-Associated Virus Serotypes in Humans and Large Animal Models for Gene Therapy

Ail D., (2026)

Interindividual variability in immune response to AAV ocular gene delivery across species impedes immunomonitoring

Ren D. et al, (2026), JCI Insight, 11

Ocular gene therapy mediated by AAV vectors: an overview of immunosuppressive treatments and immunomonitoring of patients involved in clinical trials

Ren D. et al, (2026), Progress in Retinal and Eye Research, 111, 101443 - 101443

AAV-delivered CRISPR-Cas9 elicits persistent retinal immune responses compared with transient responses to RNP

Pulman J. et al, (2025)

Inducible nonhuman primate models of retinal degeneration for testing end-stage therapies

Ail D. et al, (2023), Science Advances, 9

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?

Ail D. et al, (2023), The Application of Clinical Genetics, Volume 16, 111 - 130

Pre-existing neutralizing antibodies against different adeno-associated virus serotypes in humans and large animal models for gene therapy (Preprint)

Ail D. and Dalkara D., (2022)

Inducible non-human primate models of retinal degeneration for testing end stage therapies and understanding disease mechanisms

Ail D. et al, (2022)

Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy

Ren D. et al, (2022), Pharmaceutics, 14, 1973 - 1973

Stanniocalcin2, but Not Stanniocalcin1, Responds to Hypoxia in a HIF1-Dependent Manner in the Retina

Ail D. et al, (2022), Frontiers in Neuroscience, 16

Systemic and local immune responses to intraocular AAV vector administration in non-human primates

Ail D. et al, (2022), Molecular Therapy - Methods & Clinical Development, 24, 306 - 316

Linking YAP to Müller Glia Quiescence Exit in the Degenerative Retina

Hamon A. et al, (2019), Cell Reports, 27, 1712 - 1725.e6

Hif1a inactivation rescues photoreceptor degeneration induced by a chronic hypoxia-like stress

Barben M. et al, (2018), Cell Death & Differentiation, 25, 2071 - 2085

Müller glial cell reactivation in Xenopus models of retinal degeneration

Langhe R. et al, (2017), Glia, 65, 1333 - 1349

Retinal Degeneration and Regeneration—Lessons From Fishes and Amphibians

Ail D. and Perron M., (2017), Current Pathobiology Reports, 5, 67 - 78

Load More